Employer Info Session: ADMA Biologics
Employer Info Session with ADMA Biologics
Thursday, May 26, 2022
3pm via Zoom
ADMA Biologics is an end-to-end biopharmaceutical company with three FDA-licensed approved products including ASCENIV™ (Immune Globulin Intravenous – slra, Human), BIVIGAM® (Immune Globulin Intravenous, Human), and NABI-HB® (hepatitis B immune globulin, human). ADMA’s mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations. Ms. Kestenberg, VP of Compliance, Project Management, and Clinical Operations and Ms. Keigher, Director Analytical and Process Development will present information on the company and career opportunities, followed by a Q&A session. Advance registration is required.
As Vice President of Compliance, Project Management and Clinical Operations for ADMA Biologics, Ms. Kestenberg is responsible for ensuring Company activities comply with regulations and the expectations of governing bodies as well as oversees company-wide project planning, project management and oversight for clinical programs and operations.
Ms. Kestenberg has over 12 years of project management and clinical operations experience including successful phase 3 clinical trials and subsequent regulatory filings. She was responsible for all operational aspects and site management and oversite of ADMA’s Phase III clinical program used as the basis for ADMA’s drug approval for ASCENIV™. She has led cross-functional teams across numerous therapeutic areas including immunology, infectious diseases, multiple sclerosis, congestive heart failure, acute spinal cord injury, HIV, hepatitis Clostridioides difficile, and diabetes.
Ms. Kestenberg joined ADMA Biologics as Clinical Research Manager in 2011 and Prior to joining ADMA, she held roles of increasing responsibility in clinical operations, quality operations and compliance at Acorda Therapeutics and Merck.
Ms. Keigher joined ADMA, this year, as Director of Analytical and Process Development. Prior to joining ADMA, Ms. Keigher was Site Lead for CSL Behring’s Product Development Innovation Center, where she led many successful initiatives. Laura has held roles in Quality, R&D, Analytical Development, Process and Product Development. A key component of Laura’s success has been a focus on business centered innovation and development.
Over the past 15 years, Laura Keigher has been a scientific and thought leader in many roles throughout the pharmaceutical industry, including start-ups, government, and academic labs. Laura relies on her diverse background and proven ability to build productive teams in her current role. Success in her current role is supported by her experience in technical roles, team building, and global project and portfolio management across a variety of disciplines.
Courntey Cocilova, PhD
Courntey Cocilova, PhD, Analytical Development Scientist II is currently leading development for cell-based biological assays, and ELISA methods, for ADMA. Courtney joined ADMA 2.5 years ago and has taken on increasingly challenging projects for the company. Courtney develops and qualifies new analytical methods. She oversees the automation testing laboratory for donor screening to support hyperimmune products.
Dr. Cocilove has over 12 years of laboratory research experience, and has taken on roles of increasing responsibility throughout her career. Prior to joining ADMA, Courtney held senior level scientist positions at Micelle BioPharma, Sancilio & Company and Organic Science.
Maureen Garrity, Human Resources Manager
Mandy Perez, Manager, Human Resources Technology